Organisation paid for research Program year 2025 Source: CMS Open Payments

The DOCS LLC

Neither a doctor nor a teaching hospital

Research payments

$264,106

255 payments

Through program year 2025, The DOCS LLC is reported as receiving $264,106 in research payments, across 255 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$4,121	5
2024	Research	$100,329	237
2023	Research	$24,976	8
2022	Research	$129,269	4
2019	Research	$5,410	1

Breakdown

Who paid Research payments · program years 2019–2025

Mannkind Corporation $161,582 222 payments
Ascendis Pharma, Inc. $81,515 28 payments
OPKO Pharmaceuticals, LLC $9,749 1 payment
Sanofi US Services Inc. $5,850 3 payments
Dexcom, Inc. $5,410 1 payment

Studies the money was for Research payments · program years 2019–2025

Inhale-1 $161,582 222 payments
SkybriGHt $34,262 7 payments
SkyPASS $24,013 6 payments
New InsiGHts $19,119 10 payments
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children $9,749 1 payment
A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Trial Comparing the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naive People With Type 2 Diabetes Mellitus and Renal Impairment: TRENT Trial $5,850 3 payments
Commited $5,410 1 payment
SkyPASS $2,679 3 payments
SkybriGHt $1,442 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.